SBRT Misses the Mark in Prostate Cancer Trial
(MedPage Today) -- Stereotactic body radiotherapy (SBRT) for localized prostate cancer did not improve urinary irritation or disease-free-survival (DFS) compared with hypofractionated intensity-modulated radiotherapy (IMRT), a large randomized...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.